AUS
NZ
UK
CA
USA
IND
Healthcare
How Is GeneDx Holdings (NASDAQ:WGSWW) Adapting to Shifts in the Healthcare Market?
March 04, 2025 12:00 AM PST| By Team Kalkine MediaHighlights,GeneDx Holdings experienced a significant decrease in short interest, reflecting shifts in market positioning.,The short-interest ratio remains low, suggesting limited bearish pressure on the stock.,GeneDx operates in the genomics sector,...
How Has Market Activity Shaped Y-mAbs Therapeutics (NASDAQ:YMAB) Stock Performance?
March 04, 2025 12:00 AM PST| By Team Kalkine MediaHighlights,Y-mAbs Therapeutics remains active in the biopharmaceutical sector, with financial firms providing updated stock ratings.,The company’s stock has shown fluctuations, currently trading near its yearly low, with institutional firms maintaini...
How Has Teladoc Health's Stock Performance Shifted This Quarter? (NYSE:TDOC)
March 04, 2025 12:00 AM PST| By Team Kalkine MediaHighlights,Several financial firms adjusted their positions in Teladoc Health, with notable increases and reductions.,The stock has experienced fluctuations, trading near its lower range over the past year.,Revenue figures aligned with expectations,...
TuHURA Biosciences (NASDAQ:HURA) and Its Position in the Immuno-Oncology Market
March 04, 2025 12:00 AM PST| By Team Kalkine MediaHighlights,TuHURA Biosciences has gained attention from financial firms providing coverage and evaluations.,Recent market performance reflects fluctuations, with a notable 52-week range.,Several entities have adjusted their holdings, showcasing engag...
Is argenx SE (NASDAQ:ARGX) Expanding Its Role in the Biotechnology Sector?
March 04, 2025 12:00 AM PST| By Team Kalkine MediaHighlights,Rhumbline Advisers increased its stock position in argenx SE, reflecting ongoing institutional engagement.,Other hedge funds and financial institutions have also adjusted their holdings in argenx SE, reinforcing market interest.,The compan...
Why Are Institutional Firms Adjusting Their Holdings in Janux Therapeutics (NASDAQ:JANX)?
March 04, 2025 12:00 AM PST| By Team Kalkine MediaHighlights,Institutional investors, including Rhumbline Advisers, have made adjustments to their holdings in Janux Therapeutics.,Market activity reflects changes in financial participation, with several firms increasing or modifying positions.,Janux...
How Is Medtronic (NYSE:MDT) Adapting to Healthcare Market Changes?
March 04, 2025 12:00 AM PST| By Team Kalkine MediaHighlights,Medtronic reported earnings that included an expense attributed to unusual items, affecting its profit figures.,The company’s financial structuring and revenue trends indicate continued engagement in the healthcare sector.,Market participa...
How Is Cybin Inc. (NYSE:CYBN) Advancing Psychedelic-Based Therapies?
March 04, 2025 12:00 AM PST| By Team Kalkine MediaHighlights,Global Retirement Partners LLC acquired 5,250 shares in Cybin Inc., valued at around $46,000, as per SEC filings.,Recent research reports from Canaccord Genuity Group and HC Wainwright have adjusted price targets while maintaining positive...
Is U.S. Physical Therapy (NYSE:USPH) Maintaining Stability Amid Market Changes?
March 04, 2025 12:00 AM PST| By Team Kalkine MediaHighlights,Principal Financial Group Inc. increased its stake in U.S. Physical Therapy, reflecting heightened institutional interest.,Market evaluations of the company vary, with diverse ratings assigned by research firms.,U.S. Physical Therapy maint...
What’s Behind the Recent Investment Moves in Pacira BioSciences (NASDAQ:PCRX)?
March 04, 2025 12:00 AM PST| By Team Kalkine MediaHighlights,Institutional investors made notable adjustments to their Pacira BioSciences stakes, with some reducing holdings while others increased exposure.,Several equities experts updated their ratings and market perspectives on Pacira BioSciences...
Can Immunovant Redefine Biopharmaceutical Innovation?
March 03, 2025 11:26 PM PST| By Team Kalkine MediaHighlights,Immunovant (NASDAQ:IMVT) has received varied expert commentary.,Company executives engaged in significant share transactions.,Institutional investment positions underwent notable changes in the recent quarter.,Immunovant (NASDAQ:IMVT) oper...
Is National HealthCare Reshaping Healthcare Services?
March 03, 2025 11:26 PM PST| By Team Kalkine MediaHighlights,The stock has experienced notable fluctuations within a broad trading range.,A quarterly dividend underscores stable fiscal management.,Widespread institutional participation reinforces the company’s diversified service operations.,Nationa...
Senseonics (NYSE: SENS) Sees 56% Growth in Patient Base Following FDA Approval of Eversense® 365 CGM System
March 03, 2025 07:37 PM PST| By Team Kalkine MediaHighlights,FDA approval and US launch of Eversense® 365 CGM system drives 56% patient base growth.,Q4 2024 revenue reached $8.3 million, with a net loss of $15.5 million.,Senseonics projects $34-38 million in global revenue for 2025 with improved mar...
Why Is Mettler-Toledo International Inc. (NYSE:MTD) Gaining Attention in the Medical Instruments Sector?
March 03, 2025 09:37 AM PST| By Team Kalkine MediaHighlights,Institutional interest in Mettler-Toledo International Inc. has increased, with several firms adjusting their holdings.,The company operates within the medical instruments sector, focusing on precision instruments and laboratory equipment....
Is Bristol-Myers Squibb (NYSE:BMY) Adapting to Industry Changes?
March 03, 2025 09:11 AM PST| By Team Kalkine MediaHighlights,Bristol-Myers Squibb remains focused on pharmaceutical innovation and strategic developments.,The company continues expanding its pipeline with new treatments and acquisitions.,Industry competition and regulatory dynamics influence its ope...
Will the End of the Quiet Period Open New Coverage Opportunities?
March 02, 2025 10:22 PM PST| By Team Kalkine MediaHighlights:,Quiet period for Drugs Made in America Acquisition (NASDAQ:DMAAU) concludes on March tenth.,SEC regulations restrict research and public communications during this period.,Underwriters are set to initiate comprehensive research coverage p...
Is Astellas Pharma Reshaping Its Industry Impact?
March 02, 2025 10:22 PM PST| By Team Kalkine MediaHighlights,Significant drop in short interest recorded during February.,Maintains a substantial market capitalization with fluctuating share price.,Integrates key treatments such as XTANDI and XOSPATA into its pharmaceutical portfolio.,Astellas Pharm...
Has AddLife AB Short Interest Shifted Dramatically?
March 02, 2025 10:22 PM PST| By Team Kalkine MediaHighlights,Short interest dropped significantly over recent weeks,The stock maintained a steady price throughout the period,Operations span Labtech and Medtech segments in healthcare and pharmaceuticals,Within the expansive realm of healthcare and ph...
Which Biotechnology Firm Leads in Innovation and Financial Strength?
March 02, 2025 10:21 PM PST| By Team Kalkine MediaWhich Biotechnology Firm Leads in Innovation and Financial Strength?
Will Cabaletta Bio Outperform VectivBio in the Biotech Space?
March 02, 2025 10:20 PM PST| By Team Kalkine MediaWill Cabaletta Bio Outperform VectivBio in the Biotech Space?
